-
Security Type
-
Common Stock
-
Categories
-
Technology
-
Min Investment
-
$192
-
Offering Date
-
October 07, 2019
-
Expected Close Date
-
November 30, 2023
-
Target Raise
-
$999.98K-1
-
No. Investors
-
511
-
Security Price
-
$10.99
-
Deal Notes
-
Security Name: Class B Non-Voting Stock
$2.50 per share
-
Valuation
-
$100,000,000
- Number of Employees
- 2
- Cash
- $128,229
- Revenue
- $4,739,387
- Short Term Debt
- $427,470
- Cost of Goods
- $1,096,113
- Long Term Debt
- $1,083,664
- Net Income
- $-7,073,744
Company Description
Fisher Wallace manufactures and markets wearable medical devices for the treatment of depression, anxiety and insomnia.
Perks
$1500+ | 42% discount on the purchase of a Fisher Wallace device
$5,000+ | Above + 2% bonus shares
$10,000+ | Above + 3% bonus shares
$20,000+ | Above + 5% bonus shares
Key Deal Facts
An FDA-Cleared, clinically validated solution for depression, anxiety and insomnia with over 50,000 patients and 10,000 prescribers in the United States
$4.7 Million net revenue in 2018 with total lifetime revenue of $23.3 Million
Named an INC 5000 fastest growing company with OTC approval in Europe, Canada, Mexico and Brazil, and recently obtained Medicaid approval in Maine (MaineCare)
Use of Proceeds
StartEngine Platform Fees: 3.5%,
Marketing: 50.5%,
Research & Development: 46.0
Management Team / Advisory Board Bios
Kelly Roman
Co-Founder & CEO & Director
For the past decade, Kelly Roman has helped lead the fields of neuromodulation product development, regulatory affairs, healthcare marketing and clinical trial strategy. Prior to co-founding Fisher Wallace, Kelly graduated from Harvard and served as an award-winning executive in the digital advertising and SaaS industries. He currently serves on the boards of two charter high schools in New York City.
Charles Fisher
Co-Founder & Chairman & Director
Charles “Chip†Fisher grew up in the electronics business before helping pioneer the neuromodulation industry - his father, Avery Fisher, founded Fisher Radio (later named Fisher Electronics). After graduating from Harvard and serving as a sales executive at IBM, Chip acquired the original intellectual property to the Fisher Wallace Stimulator and is the company’s largest shareholder - and recent TEDx contributor.
Deal Notes
Security Name: Class B Non-Voting Stock
$2.50 per share